Cargando…

Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC

Non-small cell lung cancer (NSCLC) is one of the most malignant epithelial tumors. Studies have suggested that DNA hypermethylation of promoters and abnormal histone modifications could induce tumor suppressor genes (TSGs) downregulation in NSCLC. However, the exact mechanism of TSGs downregulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongling, Da, Dezhuan, Yu, Wenqiang, Chen, Lu, Yang, Shuai, Zhang, Baolong, Wang, Yongying, Li, Linyu, Dang, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838096/ https://www.ncbi.nlm.nih.gov/pubmed/35921230 http://dx.doi.org/10.1093/hmg/ddac185

Ejemplares similares

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
por: Zang, Shuzhi, et al.
Publicado: (2019)

miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC
por: Yang, Dong, et al.
Publicado: (2018)

The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
por: Xiang, Ying, et al.
Publicado: (2020)

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
por: Guo, Li-Hua, et al.
Publicado: (2013)

Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
por: Zhang, Tianxiang, et al.
Publicado: (2021)

miR-133: A Suppressor of Cardiac Remodeling?
por: Li, Ning, et al.
Publicado: (2018)

miR-134: A Human Cancer Suppressor?
por: Pan, Jing-Yu, et al.
Publicado: (2017)

The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Li, Shujun, et al.
Publicado: (2022)

Correlative analysis of miR-34b and p53 with pathological characteristics of NSCLC
por: Yang, Shuai, et al.
Publicado: (2019)

Melittin induces NSCLC apoptosis via inhibition of miR-183
por: Gao, Dongqi, et al.
Publicado: (2018)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop
por: Luo, Peng, et al.
Publicado: (2019)

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017)

Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
por: Simiene, Julija, et al.
Publicado: (2023)

Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
por: Yang, Qin, et al.
Publicado: (2022)

Serum starvation induces cell death in NSCLC via miR-224
por: Wang, Guoqin, et al.
Publicado: (2019)

Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
por: Yang, Jia, et al.
Publicado: (2021)

Retraction: The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2019)

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
por: Liu, Weipeng, et al.
Publicado: (2022)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction
por: Li, Chencheng, et al.
Publicado: (2015)

APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
por: Antoniali, Giulia, et al.
Publicado: (2022)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020)

miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement
por: Gu, Qin-Hua, et al.
Publicado: (2015)

Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers
por: Zhang, Xiaoying, et al.
Publicado: (2016)

Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network
por: Liang, Ying, et al.
Publicado: (2021)

Conservation of miR combo based direct cardiac reprogramming
por: Baksh, Syeda Samara, et al.
Publicado: (2022)

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

Retracted: The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Healthcare Engineering, Journal of
Publicado: (2023)

miR-26a-5p mediates TLR signaling pathway by targeting CTGF in LPS-induced alveolar macrophage
por: Li, Chunyan, et al.
Publicado: (2020)

Reduced miR-26a and miR-26b expression contributes to the pathogenesis of osteoarthritis via the promotion of p65 translocation
por: Yin, Xuefeng, et al.
Publicado: (2017)

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019)

MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
por: Cheng, Zhenshun, et al.
Publicado: (2014)

Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320
por: Bronisz, A, et al.
Publicado: (2011)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021)

miR-6539 is a novel mediator of somatic cell reprogramming that represses the translation of Dnmt3b
por: WU, Fujia, et al.
Publicado: (2017)

Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction
por: Xue, Sheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_do0va5jlhh3f8ja10sq74hhvre